ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2022
The contributing factors of resistance or sensitivity to epigenetic drugs in the treatment of AML.
Shohre Karimi Kelaye et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it